Pharmacopeia
Activated charcoal
Core pharmacology
- Class Group
Gastrointestinal adsorbent used for selected acute oral poisonings.
- Main Action
Adsorbs susceptible drugs and poisons within the gastrointestinal lumen to reduce systemic absorption; selected multiple-dose regimens can enhance elimination of particular toxins.
- Mechanism of action
High surface area binds many organic molecules by physical adsorption. Limited benefit for metals such as iron/lithium, toxic alcohols and many corrosive agents; suitability is poison specific.
- Indications Uses
Selected potentially serious oral overdoses when the ingested poison is adsorbed by charcoal and expected benefit exceeds aspiration/GI risk. Agent-specific indications apply to additional-dose charcoal for ongoing GI decontamination and multiple-dose charcoal for enhanced elimination.
- Route And Dose
Oral or via confirmed gastric tube where appropriate; adult single dose is commonly 50 g, but dosing, timing and repeat dosing require agent-specific toxicology guidance.
- Absorption
Not systemically absorbed to a clinically meaningful extent from an intact gastrointestinal tract; acts within the gut lumen.
- Adverse Effects Toxicity
Vomiting and aspiration pneumonitis, constipation, ileus and bezoar/obstruction (especially with repeated doses). May adsorb needed orally administered treatments.
- Special Points
The 2026 international toxicology consensus no longer treats 1 hour as an absolute cutoff: for selected poisons, individualised assessment supports charcoal as late as 6 hours or beyond when absorption is ongoing. Avoid charcoal with unprotected or threatened airway or significant GI obstruction/perforation risk. Do not routinely intubate solely to administer charcoal; consult a toxicologist or Poisons Information Centre.
Source references
These October 2026 additions were reconciled against the linked sources. Refer to current local formulary guidance for clinical prescribing.